Today: 7 February 2026
Subscribe

Silver price today: SLV jumps nearly 7% as silver rebounds after record-high rout

Silver price today: SLV jumps nearly 7% as silver rebounds after record-high rout

NEW YORK, December 30, 2025, 13:30 ET — Regular session Silver prices rebounded on Tuesday after a sharp pullback from record highs, pushing the iShares Silver Trust (SLV) up about 6.9% in New York trade. Spot silver was up 4.7% at $76.38 an ounce at 11:29 a.m. ET, a day after touching an all-time high of $83.62 and suffering its biggest one-day drop since August 2020. Analysts at Societe Generale pointed to CME Group’s move on Friday to raise the initial margin requirement for silver futures — the cash traders must post to hold positions — as a factor behind
30 December 2025
·····
Gold price rebounds today as Fed minutes near; GLD and Newmont stocks climb

Gold price rebounds today as Fed minutes near; GLD and Newmont stocks climb

NEW YORK, December 30, 2025, 13:25 ET — Regular session Gold prices rebounded on Tuesday and gold-linked shares traded higher in midday U.S. dealings, as investors positioned ahead of Federal Reserve minutes due later in the session. Spot gold was around $4,373 an ounce, up about 1% on the day, according to Kitco data. Kitco The swing matters now because bullion’s late-year volatility is spilling into popular “gold proxy” trades — gold-backed ETFs that hold physical metal and large miners whose profits tend to move with the gold price. Gold is up about 66% in 2025, its biggest annual gain
30 December 2025
········
Rhythm Pharmaceuticals (RYTM) stock falls today as biotech weakens; FDA decision stays in focus

Rhythm Pharmaceuticals (RYTM) stock falls today as biotech weakens; FDA decision stays in focus

NEW YORK, December 30, 2025, 13:33 ET — Regular session Rhythm Pharmaceuticals shares were down 4.2% at $107.85 at 1:33 p.m. ET on Tuesday, after trading as low as $106.65. The move matters because Rhythm is a single-product rare-disease biotech whose stock has tended to swing on regulatory and clinical milestones for Imcivree, its obesity drug. Investors are watching the company’s next U.S. Food and Drug Administration decision closely. With the next major catalyst still ahead, the stock can move sharply on broader risk sentiment in biotech, even when there is no fresh company news. The SPDR S&P Biotech ETF
30 December 2025
····
S&P 500 Slips Before Fed Minutes as Meta Rises on Manus AI Deal

S&P 500 Slips Before Fed Minutes as Meta Rises on Manus AI Deal

NEW YORK, December 30, 2025, 13:22 ET — Regular session U.S. stocks edged lower in holiday-thin trade on Tuesday, with the S&P 500 and Nasdaq near flat as investors waited for the Federal Reserve’s meeting minutes. Meta Platforms rose after saying it will buy AI startup Manus, helping support communication services shares. At 12:00 p.m. ET, the Dow fell 0.24%, the S&P 500 slipped 0.09% and the Nasdaq Composite eased 0.07%. Reuters The quiet tape matters because markets are closing out the year near record levels, and light volume can exaggerate otherwise small moves. The pause follows Monday’s pullback in
30 December 2025
·······
Warby Parker stock price today: WRBY falls nearly 4% in thin year-end trading

Warby Parker stock price today: WRBY falls nearly 4% in thin year-end trading

NEW YORK, December 30, 2025, 13:34 ET — Regular session Warby Parker Inc (WRBY) shares fell about 3.9% to $22.11 in early afternoon trading on Tuesday, after ending Monday at $23.00. The stock opened at $22.90 and traded between $21.87 and $23.13, with nearly 3 million shares changing hands; the company is valued at about $3.4 billion. The slide comes with just a handful of sessions left in 2025, a stretch when trading often thins out and price moves can look outsized. Thin trading means fewer buyers and sellers, so routine position changes can move a stock more than usual.
30 December 2025
·····
Dow Jones today: DJIA slips in thin year-end trade as Fed minutes loom

Dow Jones today: DJIA slips in thin year-end trade as Fed minutes loom

NEW YORK, December 30, 2025, 13:24 ET — Regular session The Dow Jones Industrial Average edged lower on Tuesday as investors kept positions tight ahead of Federal Reserve minutes in the final sessions of the year. The blue-chip index was down 57.44 points, or 0.12%, at 48,404.49 by 1:24 p.m. ET, while the S&P 500 and Nasdaq Composite were little changed, according to LSEG data. Reuters The muted trade matters now because year-end conditions can distort price action. With many desks lightly staffed and portfolios being rebalanced, even modest buying or selling can push indexes around more than usual. The
30 December 2025
·······
France vows stable electricity bills in 2026 — but new charges could still push costs up

France vows stable electricity bills in 2026 — but new charges could still push costs up

NEW YORK, December 30, 2025, 13:17 ET France’s economy ministry says most households should not see their electricity bills rise in 2026 and 2027 as the country enters a new pricing regime for nuclear power from Jan. 1. L’Energeek The reassurance comes just ahead of the expiry of ARENH, a long-running scheme that capped the price of part of EDF’s nuclear output and helped set the benchmark for retail electricity offers. The change matters now because it lands at the start of a new year, when households reset budgets and energy bills are a politically sensitive issue after the volatility
30 December 2025
·
Vipshop stock slides about 5% today as Jefferies flags softer December trends ahead of Fed minutes

Vipshop stock slides about 5% today as Jefferies flags softer December trends ahead of Fed minutes

NEW YORK, December 30, 2025, 1:14 PM ET — Regular session Vipshop Holdings Limited (VIPS) shares fell about 5% on Tuesday, trading around $18.39 in afternoon dealings. The drop came in a muted U.S. session with year-end liquidity thin, leaving single-stock swings more pronounced than usual. Reuters Investors are also waiting for the Federal Reserve’s minutes from its Dec. 9-10 meeting due later Tuesday, looking for signals on how policymakers see the 2026 path for interest rates. Reuters Jefferies analyst Thomas Chong reiterated a buy rating and a $22.60 price target on Vipshop. Jefferies expects fourth-quarter revenue at the low
30 December 2025
····
Corcept stock slides nearly 9% as FDA decision deadline arrives — what’s driving CORT today

Corcept stock slides nearly 9% as FDA decision deadline arrives — what’s driving CORT today

NEW YORK, December 30, 2025, 13:14 ET — Regular session Corcept Therapeutics Inc shares fell 8.9% to $72.72 in early afternoon Nasdaq trading on Tuesday, after touching a session low of $72.26. The stock was last down $7.10 from Monday’s close, with about 897,000 shares traded. The decline comes as investors focus on Corcept on the day the U.S. Food and Drug Administration is due to decide on relacorilant, its experimental treatment for endogenous hypercortisolism, also known as Cushing’s syndrome. Under the Prescription Drug User Fee Act, or PDUFA, the FDA sets a target date for taking action on a
30 December 2025
·····
D-Wave Quantum stock pops today as QBTS outperforms on year-end options buzz

D-Wave Quantum stock pops today as QBTS outperforms on year-end options buzz

NEW YORK, December 30, 2025, 1:03 PM ET — Regular session D-Wave Quantum Inc. shares climbed on Tuesday, extending a choppy year-end stretch for quantum-computing stocks as the group again outperformed a flat-to-weaker U.S. market. Reuters The move matters because quantum names have become a high-beta pocket of the tech market, with swings amplified by thin holiday liquidity and active retail trading. Investors.com said the group saw a late-December pop followed by profit-taking in the sessions that followed. Investors.com D-Wave has been one of the sector’s standout gainers in 2025, but the stock remains well off its highs, underscoring how
30 December 2025
·····
Equinox Gold stock climbs as gold rebounds — here’s what’s moving EQX today

Equinox Gold stock climbs as gold rebounds — here’s what’s moving EQX today

NEW YORK, December 30, 2025, 13:01 ET — Regular session Equinox Gold Corp shares rose about 2.2% on Tuesday, trading around $14.30, as a rebound in gold prices lifted the sector. The stock traded between $14.18 and $14.58, with about 2.2 million shares changing hands. The move matters because the gold market has turned choppy into year-end after a powerful run, and miners often magnify bullion swings. A small change in the gold price can quickly reshape expectations for miners’ cash flow. Investors are also positioning around the Federal Reserve’s December meeting minutes, due later Tuesday, for clues on how
30 December 2025
····
Target stock slips today as activist pressure stays in focus — what investors are watching next

Target stock slips today as activist pressure stays in focus — what investors are watching next

NEW YORK, December 30, 2025, 12:56 ET — Regular session Target Corp shares were down 0.7% at $97.38 in midday trading on Tuesday, lagging a modest dip across retail names. The stock’s move comes as investors keep focus on activist scrutiny of the big-box retailer, a fresh overhang after a report that hedge fund Toms Capital Investment Management has built a significant, but undisclosed, position. The Star Why it matters now: Target is trying to halt a sales slide and reset expectations with a leadership handover looming, after the company posted three straight quarters of declining comparable sales — a
30 December 2025
···
1 … 1,085 1,086 1,087 1,088 1,089 … 2,711

Stock Market Today

Vodafone shares steady up after Q3 wobble — Germany, buyback and next results now set the tone

Vodafone shares steady up after Q3 wobble — Germany, buyback and next results now set the tone

7 February 2026
Vodafone shares rose 1.47% to 110.60p Friday, recovering part of Thursday’s 4.68% drop after a Q3 update. Group revenue climbed 6.5% to €10.5 billion, but Germany’s 0.7% service revenue growth missed some forecasts. Vodafone launched a new €500 million buyback tranche, bringing total buybacks since May to €3.5 billion. Investors remain focused on Germany’s pace and cash flow execution.
NatWest Group stock: buyback filing and Rightmove mortgage deal set up a busy week

NatWest Group stock: buyback filing and Rightmove mortgage deal set up a busy week

7 February 2026
NatWest shares closed up 1.45% at 659.4 pence Friday, buoyed by a buyback of 797,428 shares and a new digital mortgage deal with Rightmove. The Bank of England held rates at 3.75% but signaled possible cuts, with markets pricing in two reductions for 2026. NatWest plans to expand its Accelerator community to 50,000 members by 2026. Annual results are due Feb. 13.
Unilever share price holds at 5,250p as results week looms — what investors watch next

Unilever share price holds at 5,250p as results week looms — what investors watch next

7 February 2026
Unilever shares closed flat at 5,250p in London Friday, underperforming the FTSE 100’s 0.6% gain. The company issued 4.2 million new shares for employee plans, bringing total shares to over 2.18 billion. Investors await Q4 and full-year results on Feb. 12, with analyst consensus pointing to 3.9% Q4 sales growth. Unilever’s U.S. ADR rose 0.8% to $72.12.
BP share price near 52-week high ahead of Feb 10 earnings as buyback runs on

BP share price near 52-week high ahead of Feb 10 earnings as buyback runs on

7 February 2026
BP shares closed up 1.9% at 478 pence Friday, just below a 52-week high, as the company continued buybacks ahead of next week’s results. BP repurchased 2.789 million shares on February 6. Oil prices firmed on geopolitical risk, with Brent at $68.05 a barrel, but sector outlook remains uncertain. Investors await BP’s earnings and dividend decision due Tuesday.
Go toTop